DIFFERENT STAKEHOLDER PERSPECTIVES ON PHARMACOGENOMIC TESTING

被引:0
|
作者
Patel, H. [1 ]
Ursan, I [1 ]
Zueger, P. [1 ]
Pickard, A. S. [1 ]
机构
[1] Univ Illinois, Chicago, IL USA
关键词
D O I
10.1016/j.jval.2013.03.1241
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A244 / A244
页数:1
相关论文
共 50 条
  • [21] Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study
    Cernat, Alexandra
    Samaan, Zainab
    Abelson, Julia
    Ramdyal, Amanada
    Shaikh, Hadia
    Vanstone, Meredith
    JOURNAL OF COMMUNITY GENETICS, 2024, 15 (03) : 293 - 309
  • [22] Pharmacogenomic perspectives on the management of mood disorders
    Alarcon, Renato D.
    PSYCHIATRIC BULLETIN, 2009, 33 (10): : 361 - 363
  • [23] Hospitality Graduate Education: A View from Three Different Stakeholder Perspectives
    Cho, Seonghee
    Erdem, Mehmet
    Johanson, Misty M.
    JOURNAL OF HOSPITALITY & TOURISM EDUCATION, 2006, 18 (04) : 45 - +
  • [24] Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study
    Srinivasan, Swetha
    Hampel, Heather
    Leeman, Jennifer
    Patel, Amit
    Rahm, Alanna Kulchak
    Reuland, Daniel S.
    Roberts, Megan C.
    CANCER PREVENTION RESEARCH, 2020, 13 (12) : 1037 - 1046
  • [25] Neurogenic dysphagia: current pharmacogenomic perspectives
    Guerra, Joaquin
    Naidoo, Vinogran
    Cacabelos, Ramon
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2022, 6 (03) : 304 - 321
  • [26] Stakeholder Perspectives on MAPS
    Sanchez, Amanda L.
    Hoskins, Katelin
    Pettit, Amy R.
    Momplaisir, Florence
    Gross, Robert
    Brady, Kathleen A.
    Hoffacker, Carlin
    Zentgraf, Kelly
    Beidas, Rinad S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 : S190 - S196
  • [27] Adoption of Pharmacogenomic Testing: A Marketing Perspective
    Koufaki, Margarita-Ioanna
    Karamperis, Kariofyllis
    Vitsa, Polixeni
    Vasileiou, Konstantinos
    Patrinos, George P.
    Mitropoulou, Christina
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Erlotinib and patterns of pharmacogenomic (PGx) testing
    De Souza, Jonas A.
    Gleason, Patrick P.
    Starner, Catherine I.
    Qiu, Yang P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [29] Misleading Guidance From Pharmacogenomic Testing
    Rahman, Tahir
    Ash, David M.
    Lauriello, John
    Rawlani, Roshni
    AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (10): : 922 - 924
  • [30] Pharmacogenomic Testing and Personalized Treatment of Depression
    Perlis, Roy H.
    CLINICAL CHEMISTRY, 2014, 60 (01) : 53 - 59